COVID-19: another reason for anticoagulation in patients with atrial fibrillation

Heart. 2022 May 25;108(12):902-904. doi: 10.1136/heartjnl-2022-320845.

Authors

Pekka Raatikainen¹, Riitta Lassila²

Affiliations

¹ Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland pekka.raatikainen@hus.fi.
² Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Center, Helsinki University Hospital, and Reserach Program Unit of Systems Oncology, University of Helsinki, Helsinki, Finland, Helsinki, Finland.

PMID: 35314451
DOI: 10.1136/heartjnl-2022-320845

No abstract available

Keywords: COVID-19; atrial fibrillation; pharmacology, clinical; stroke.

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Blood Coagulation
COVID-19*
Humans
Risk Factors
Stroke*

Substances

Anticoagulants